Pharmacotherapy for Allergic Rhinitis

Abstract

Although the treatment of allergic rhinitis has become widespread with the advent of anti-IgE antibody preparations, the focus of treatment remains on second-generation antihistamines. We conducted a questionnaire survey, which was delivered via email to otolaryngologists in Saga prefecture and neighboring areas, to investigate pharmacotherapy for allergic rhinitis. Bilastine was the agent most frequently prescribed to otolaryngologists themselves, their family members, and their patients. The prevalence of allergic rhinitis is increasing, and it is important to conduct treatment while considering the effects of each drug, the ease of use, and the presence or absence of side effects.